EUVIMEDEUVIMED entdecken
Kohortenstudie

Characteristics, Treatment Patterns and Clinical Outcomes of Women with Maghreb Origin and Diagnosis of Breast Cancer: A Single-Center, Retrospective Cohort Study

Chiara Dauccia, Diogo Martins-Branco, Michel Moreau, Lieveke Ameye, Elisa Agostinetto, Luca Arecco, Soraia Lobo-Martins, Anja Skoporc, Isabel Vilas-Boas, Masa Auprih, Ahmad Awada, Véronique Debien und 1 weitere

Clinical Breast Cancer · 2025

DOI: 10.1016/j.clbc.2025.06.011 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Clinical Breast Cancer, 2025. Verfasst von Chiara Dauccia und 12 weiteren Autor:innen. Beteiligte Einrichtung: Université libre de Bruxelles (ULB), Hôpital Universitaire de Bruxelles (H.U.B), Institut Jules Bordet, Bruxelles, Belgium; Department of Internal Me…. Hauptthemen laut MEDLINE: Breast Neoplasms, Arabs. Die Arbeit nennt 31 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Disparities in breast cancer (BC) prevention, screening, treatment access, and survival based on ethnicity have been described. Data in Arab population are limited. We aimed to dissect differences in BC characteristics and outcomes among patients of Maghreb versus non-Maghreb origin. METHODS: We retrospectively analyzed women of Maghreb origin treated at Institut Jules Bordet for invasive BC between January 2000 and September 2018. Maghreb origin was identified by birthplace and/or first name. A sample of non-Maghreb patients was used for comparison. Multivariate models were adjusted for clinically relevant confounders. RESULTS: We identified 282 Maghreb-origin patients and 277 non-Maghreb origin patients. At diagnosis, Maghreb-origin patients were younger (49.3 y, interquartile range [IQR] 40.8-58.1 vs. 62 y, IQR 52.3-72.2), had larger tumors, more clinical node-positive disease (37.6 vs. 22.5%) and more frequently presented symptoms (77.5% vs. 60.9%) (all P < .001). Maghreb-origin patients had a higher proportion of grade 3 (51.3% vs. 29.2%), HER2-positive (22.5% vs. 14.2%) and triple-negative (14.2% vs. 6.6%) tumors and more frequently received neoadjuvant chemotherapy (39.4% vs. 15.5%) and axillary lymph node dissections (73.9% vs. 56.1%) (all P < .001). After a median follow-up of 7.2 years, no statistically significant differences in iDFS (adjusted HR 1.11, 95% CI 0.72-1.73) or OS (adjusted HR 1.40, 95% CI 0.81-2.42) were observed. CONCLUSIONS: Despite the younger age and more aggressive BC, survival outcomes in patients of Maghreb vs. non-Maghreb origin did not differ. These results underscore the importance of considering ethnic minority populations to develop tailored prevention strategies and improve their inclusion in clinical trials.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsArabsHumansFemaleRetrospective StudiesMiddle AgedAgedAdultNeoadjuvant TherapyChemotherapy, AdjuvantFollow-Up StudiesPrognosis

Stichwörter der Autor:innen

Arab originBreast neoplasmsMaghreb populationMinorityTreatments

Autor:innen und Institutionen

  • Université libre de Bruxelles (ULB), Hôpital Universitaire de Bruxelles (H.U.B), Institut Jules Bordet, Bruxelles, Belgium; Department of Internal Medicine and Medical Therapy, University of Pavia, Pavia, Italy.
  • Université libre de Bruxelles (ULB), Hôpital Universitaire de Bruxelles (H.U.B), Institut Jules Bordet, Bruxelles, Belgium.
  • Institute of Oncology Ljubljana, Ljubljana, Slovenia.
  • Instituto Português de Oncologia do Porto Francisco Gentil, Porto, Portugal.
  • Medical Oncology Department, Université Libre de Bruxelles (ULB), Hôpital Universitaire de Bruxelles (HUB), Institut Jules Bordet, Brussels, Belgium.
  • Université libre de Bruxelles (ULB), Hôpital Universitaire de Bruxelles (H.U.B), Institut Jules Bordet, Bruxelles, Belgium; Institut Bergonié, Early Phase Trials Unit, Bordeaux, France.

Zitieren

APA

Dauccia, C., Martins-Branco, D., Moreau, M., Ameye, L., Agostinetto, E., Arecco, L., Lobo-Martins, S., Skoporc, A., Vilas-Boas, I., Auprih, M., Awada, A., Debien, V., & de Azambuja, E. (2025). Characteristics, Treatment Patterns and Clinical Outcomes of Women with Maghreb Origin and Diagnosis of Breast Cancer: A Single-Center, Retrospective Cohort Study. Clinical Breast Cancer. https://doi.org/10.1016/j.clbc.2025.06.011

Vancouver

Dauccia C, Martins-Branco D, Moreau M, Ameye L, Agostinetto E, Arecco L, et al. Characteristics, Treatment Patterns and Clinical Outcomes of Women with Maghreb Origin and Diagnosis of Breast Cancer: A Single-Center, Retrospective Cohort Study. Clinical Breast Cancer. 2025. doi:10.1016/j.clbc.2025.06.011

BibTeX
@article{Dauccia2025,
  author = {Dauccia, Chiara and Martins-Branco, Diogo and Moreau, Michel and Ameye, Lieveke and Agostinetto, Elisa and Arecco, Luca and Lobo-Martins, Soraia and Skoporc, Anja and Vilas-Boas, Isabel and Auprih, Masa and Awada, Ahmad and Debien, Véronique and de Azambuja, Evandro},
  title = {Characteristics, Treatment Patterns and Clinical Outcomes of Women with Maghreb Origin and Diagnosis of Breast Cancer: A Single-Center, Retrospective Cohort Study},
  journal = {Clinical Breast Cancer},
  year = {2025},
  doi = {10.1016/j.clbc.2025.06.011}
}
Kostenlos starten →